Illumina (ILMN) Accumulated Expenses (2010 - 2026)
Illumina's (ILMN) quarterly Accumulated Expenses came in at $848.0 million in Q2 2026, up 11.29% on a YoY basis from $762.0 million in Q2 2025, and little changed quarter-over-quarter from $849.0 million in Q1 2026.
Analysis
Illumina (ILMN) Accumulated Expenses (2010 - 2026) Analysis & Trends
Illumina (ILMN) has reported Accumulated Expenses for 17 consecutive years, with $848.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Accumulated Expenses rose 11.29% year-over-year to $848.0 million; the trailing twelve-month figure through Jun 2026 stood at $848.0 million (up 11.29% YoY), and the FY2025 full-year result was $846.0 million, up 2.3% from the prior year.
- Accumulated Expenses held at $848.0 million in Q2 2026 per ILMN's latest filing, from $849.0 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $1.4 billion in Q3 2022 and bottomed at $700.0 million in Q2 2022.
- Historically, Accumulated Expenses has averaged $1.0 billion across 5 years, with a median of $849.0 million in 2026.
- The sharpest annual moves came in 2022 and 2025: Accumulated Expenses surged 100.89% in 2022, then slumped 42.34% in 2025.
- Over 5 years, Accumulated Expenses stood at $1.1 billion in 2022, then grew by 16.02% to $1.3 billion in 2023, then slumped by 37.58% to $827.0 million in 2024, then gained by 2.3% to $846.0 million in 2025, then rose by 0.24% to $848.0 million in 2026.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $848.0 million, $849.0 million, and $846.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 848.00 Mn |
| Mar 29, 2026 | 849.00 Mn |
| Dec 28, 2025 | 846.00 Mn |
| Sep 28, 2025 | 746.00 Mn |
| Jun 29, 2025 | 762.00 Mn |
| Mar 30, 2025 | 734.00 Mn |
| Dec 29, 2024 | 827.00 Mn |
| Sep 29, 2024 | 784.00 Mn |
| Jun 30, 2024 | 1.27 Bn |
| Mar 31, 2024 | 1.27 Bn |
| Dec 31, 2023 | 1.33 Bn |
| Oct 1, 2023 | 1.24 Bn |
| Jul 2, 2023 | 1.31 Bn |
| Apr 2, 2023 | 1.24 Bn |
| Jan 1, 2023 | 1.23 Bn |
| Oct 2, 2022 | 1.14 Bn |
| Jul 3, 2022 | 1.35 Bn |
| Apr 3, 2022 | 700.00 Mn |
| Jan 2, 2022 | 761.00 Mn |
| Oct 3, 2021 | 666.00 Mn |